This review summarizes the progressive molecular events linking Αβ and tau pathology to neuroinflammation via the P2X7R-NLRP3 inflammasome axis, while underscoring the therapeutic potential of plant-derived bioactive compounds as well as synthetic molecules in mitigating the progression of Alzheimer’s disease.
Rishabh Goswami, Nidhi Sharma, V. Jhawat et al.· Asian Pacific Journal of Tro...· 0 citations
The rapid evolution of KRAS-targeted therapeutic agents represents a shift from allele-specific inhibition towards a strategy that is mutation/context-dependent, thereby creating further clinical translation opportunities and increased patient benefit.
Srijita Chatterjee, S. Arya, Nidhi Sharma et al.· Medical Oncology· 0 citations
The present review aims to delve into the potential mechanism of action of Dalbergia sissoo in Alzheimer’s disease, focusing on the interaction between the P2X7 receptor and NLRP3 inflammasome.
Rishabh Goswami, A. Rai, D. Dhull et al.· Journal of Dynamics and Cont...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.